fluoxetine has been researched along with scopolamine hydrobromide in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 8 (44.44) | 18.2507 |
| 2000's | 5 (27.78) | 29.6817 |
| 2010's | 3 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Adkison, KK; Humphreys, JE; Mahar Doan, KM; Polli, JW; Serabjit-Singh, CJ; Shampine, LJ; Webster, LO; Wring, SA | 1 |
| Both, FL; Elisabetsky, E; Henriques, AT; Kerber, VA; Meneghini, L | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Andreev, BV | 1 |
| Janowsky, DS; Overstreet, DH; Rezvani, AH | 1 |
| Baker, GB; Robertson, B; Vanderwolf, CH | 1 |
| Holmgren, B; Urbá-Holmgren, R | 1 |
| Callaway, CW; Geyer, MA; Rempel, NL | 1 |
| Hong, E; Meneses, A | 1 |
| Kulkarni, SK; Kumar, S | 1 |
| Chodera, A; Kus, K; Nowakowska, E | 1 |
| Daws, LC; Frazer, A; Lopez, R | 1 |
| Chau, D; Hoebel, BG; Kosloff, RA; Rada, PV | 1 |
| Diavolitsis, P; Dringenberg, HC | 1 |
| Caboche, J; Girault, JA; Hervé, D; Pagès, C; Valjent, E | 1 |
| Baker, SJ; Boyce-Rustay, JM; Decker, MW; Honore, P; Kohnken, R; Simler, GH; Wensink, EJ; Zhong, C | 1 |
1 review(s) available for fluoxetine and scopolamine hydrobromide
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
17 other study(ies) available for fluoxetine and scopolamine hydrobromide
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Dogs; Drug Delivery Systems; Permeability; Pharmaceutical Preparations | 2002 |
Psychopharmacological profile of the alkaloid psychollatine as a 5HT2A/C serotonin modulator.
Topics: Anti-Anxiety Agents; Brazil; Diazepam; Glycosides; Indole Alkaloids; Memory; Models, Biological; Molecular Structure; Monoterpenes; Plants, Medicinal; Psychopharmacology; Psychotria; Receptors, GABA-A; Receptors, Serotonin; Serotonin Receptor Agonists | 2005 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
[Role of cholinergic and serotoninergic processes in modulating the activity of the negative reinforcement system].
Topics: Acetylcholine; Animals; Escape Reaction; Fluoxetine; Hypothalamus; Hypothalamus, Middle; Male; Mesencephalon; p-Chloroamphetamine; Physostigmine; Rats; Reaction Time; Scopolamine; Serotonin | 1978 |
Drug-induced reductions in ethanol intake in alcohol preferring and Fawn-Hooded rats.
Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Drinking Behavior; Ethanol; Feeding Behavior; Fluoxetine; Male; Pindolol; Piperazines; Rats; Rats, Inbred Strains; Rats, Wistar; Scopolamine; Self Administration; Serotonin Receptor Agonists; Species Specificity; Verapamil | 1991 |
The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Benserazide; Cerebral Cortex; Electroencephalography; Fluoxetine; Hippocampus; Male; Metergoline; Motor Activity; p-Chloroamphetamine; Rats; Scopolamine; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Tranylcypromine; Tryptophan | 1991 |
Interaction of cholinergic and dopaminergic influences on yawning behavior.
Topics: Animals; Apomorphine; Behavior, Animal; Benzofurans; Citalopram; Fluoxetine; Metergoline; Physostigmine; Propylamines; Rats; Receptors, Cholinergic; Receptors, Dopamine; Scopolamine; Spiperone | 1980 |
Serotonin1B receptor activation mimics behavioral effects of presynaptic serotonin release.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Behavior, Animal; Caffeine; Designer Drugs; Dopamine Agents; Dose-Response Relationship, Drug; Fluoxetine; Indoles; Male; Motor Activity; N-Methyl-3,4-methylenedioxyamphetamine; Nicotine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Scopolamine; Serotonin; Serotonin Receptor Agonists; Synapses | 1993 |
Effect of fluoxetine on learning and memory involves multiple 5-HT systems.
Topics: Animals; Cholinergic Antagonists; Conditioning, Operant; Dextroamphetamine; Dizocilpine Maleate; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluoxetine; Injections, Intraperitoneal; Learning; Male; Memory; Parasympatholytics; Rats; Rats, Wistar; Scopolamine; Selective Serotonin Reuptake Inhibitors; Serotonin; Sympathomimetics; Synaptic Transmission | 1995 |
Influence of antidepressant drugs on learning and memory paradigms in mice.
Topics: Aged; Amitriptyline; Animals; Antidepressive Agents; Depression; Female; Fluoxetine; Humans; Imipramine; Learning; Male; Memory; Mice; Muscarinic Antagonists; Scopolamine | 1996 |
Pharmacological activity of fluoxetine.
Topics: Animals; Anti-Anxiety Agents; Exploratory Behavior; Fluoxetine; Male; Memory; Motor Activity; Muscarinic Antagonists; Rats; Rats, Wistar; Scopolamine; Selective Serotonin Reuptake Inhibitors | 1996 |
Effects of antidepressant treatment on inhibitory avoidance behavior and amygdaloid beta-adrenoceptors in rats.
Topics: Adrenergic beta-Antagonists; Amygdala; Animals; Antidepressive Agents; Avoidance Learning; Desipramine; Fluoxetine; Injections, Intraventricular; Male; Muscarinic Antagonists; Phenelzine; Propranolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-1; Scopolamine | 1998 |
Cholinergic, M1 receptors in the nucleus accumbens mediate behavioral depression. A possible downstream target for fluoxetine.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acetylcholine; Animals; Arecoline; Depression; Female; Fluoxetine; Microinjections; Motor Activity; Nucleus Accumbens; Pirenzepine; Posture; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M1; Receptors, Muscarinic; Scopolamine; Swimming | 1999 |
Electroencephalographic activation by fluoxetine in rats: role of 5-HT(1A) receptors and enhancement of concurrent acetylcholinesterase inhibitor treatment.
Topics: Alpha Rhythm; Animals; Antipsychotic Agents; Cholinesterase Inhibitors; Data Collection; Electroencephalography; Fluoxetine; Male; Muscarinic Antagonists; Piperazines; Pyridines; Rats; Rats, Long-Evans; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reserpine; Scopolamine; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Tacrine | 2002 |
Addictive and non-addictive drugs induce distinct and specific patterns of ERK activation in mouse brain.
Topics: Adrenergic Uptake Inhibitors; Analgesics, Non-Narcotic; Analgesics, Opioid; Animals; Benzazepines; Brain; Caffeine; Central Nervous System Stimulants; Cocaine; Desipramine; Dopamine Antagonists; Dronabinol; Enzyme Activation; Fluoxetine; Immunohistochemistry; Male; Mice; Mitogen-Activated Protein Kinases; Morphine; Muscarinic Antagonists; Neurons; Nicotine; Nicotinic Agonists; Scopolamine; Selective Serotonin Reuptake Inhibitors | 2004 |
Comparison of mechanical allodynia and the affective component of inflammatory pain in rats.
Topics: Analgesics, Non-Narcotic; Animals; Behavior, Animal; Celecoxib; Central Nervous System Agents; Diclofenac; Disease Models, Animal; Dose-Response Relationship, Drug; Duloxetine Hydrochloride; Escape Reaction; Fluoxetine; Inflammation; Male; Motor Activity; Neuropsychological Tests; Pain; Pain Measurement; Physical Stimulation; Pyrazoles; Rats; Rats, Sprague-Dawley; Scopolamine; Sulfonamides; Thiophenes; Treatment Outcome | 2010 |